vania-janet/multiturn-rag-retrieval-data huggingface dataset:
Clinical Care Quick Reference for COVID-19 | CDC
Post-COVID conditions describe a range of new, returning, or ongoing health issues that persist four or more weeks after a person is first infected with the virus that causes COVID-19, sometimes after initial symptom recovery.

New or ongoing symptoms can occur in people who had varying degrees of illness during acute infection, including patients who had mild or asymptomatic infections.
Medical and research communities are still learning about post-acute symptoms and clinical findings.

Get more details: Evaluating and Caring for Patients with Post-COVID Conditions
QUICK REFERENCECaring for Special Populations

For healthcare providers caring for children, CDC provides information about caring for children with suspected or confirmed COVID-19.

MORE DETAILS

Caring for Children

QUICK REFERENCEReinfection

Reinfection with the virus that causes COVID-19 means a person was infected, recovered, and then later became infected again.
Most people will have some protection from reinfection, but the emergence of variants (new strains of the virus) can increase the risk of reinfection.

Get more details: Reinfections and COVID-19


	Last Updated May 22, 2024	Source: 	National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases

Facebook
Twitter
LinkedIn
Syndicate
Covid-19 Vaccines


Post-Vaccine COVID-19 Cases Right imagePost-Vaccine COVID-19 Cases http://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/man-looks-at-thermometer-under-blanket-464x480.png, Man looks at a thermometer as he lays under a blanket1<p>​​Post-vaccination cases are individuals who are fully vaccinated and have a positive SARS-CoV-2 molecular (e.g. PCR) test 14 days or more after they have completed their full one-dose or two-dose COVID-19 vaccination series. They are also referred to as vaccine breakthrough cases.<br></p><p><span data-contrast="auto" lang="EN-US"></span><a href="/Programs/CID/DCDC/Pages/COVID-19/Post-Vaccine-COVID19-Cases.aspx" target="_blank"><span data-contrast="auto" lang="EN-US">Learn About Breakthrough Cases</span></a><span data-contrast="auto" lang="EN-US"></span><br></p>https://covid19.ca.gov/state-dashboard/#postvax-status, See Data by Vaccination Status

 
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.

 
COVID-19 Vaccine ToolkitsRight imageCOVID-19 Vaccine Toolkitshttp://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/Body-Image-GettyImages-1303044387%20(1).png, Woman in car after receiving vaccine1<p>​​​Let's work together to keep our communities healthy. Help spread the word about how Californians can protect themselves and their families against COVID-19. The Toolkits include ready-to-use graphics and copy that can be easily shared to help local public health departments and community groups raise awareness about the importance of COVID-19 vaccines.
Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers | FDA
Q: What if I get different results on two SARS-CoV-2 antibody tests and they don't agree? Which one is right?
A: Results may be different for several reasons, including:
The design of the tests - different antibody tests may detect different antibodies and different levels of antibodies.
The performance of the tests, including the sensitivity and specificity of each test (see What do sensitivity and specificity mean in SARS-CoV-2 antibody testing below).
The timing of when you took the tests, how long it may take for your body to develop antibodies after a potential SARS-CoV-2 infection, and whether antibody levels may decrease over time.
For this and other reasons, you should always review your test results with your health care provider.
Q: What is the difference between qualitative, quantitative, and semi-quantitative SARS-CoV-2 antibody tests? What do the reported numbers mean?
A: Qualitative, semi-quantitative, and quantitative tests all tell you if SARS-CoV-2 antibodies were detected in your blood sample with the specific test used. These tests report whether SARS-CoV-2 antibodies were detected or not detected over a certain threshold, and this threshold may vary between different SARS-CoV-2 antibody tests. Different antibody tests may also be designed to detect different SARS-CoV-2 antibodies in addition to the different levels of antibodies. This means that different tests may provide different results for the same blood sample.
Qualitative SARS-CoV-2 antibody tests only report whether SARS-CoV-2 antibodies were detected or not detected and do not provide any indication of the amount of antibodies detected, other than whether it was above or below the detection threshold for that test.
Semi-quantitative SARS-CoV-2 antibody tests also report the relative concentration of antibodies in a person's blood sample at the time of testing, meaning the level of antibody in your blood sample is assigned a number on a scale that applies only to that specific authorized test.
Post-COVID Conditions: Information for Healthcare Providers
Overview and MethodsCOVID-19 Data SourcesForecastingplus iconHospital ForecastsVariant Surveillanceplus iconGenomic SurveillanceTracking VariantsHealthcare Workersplus iconClinical Careplus iconQuick ReferenceClinical Care ConsiderationsOutpatient Treatment OverviewUnderlying Medical ConditionsChildrenPost-COVID Conditions: Healthcare ProvidersPost-COVID Conditions: CDC ScienceTestingplus iconTesting OverviewAntibody TestingInfection Control Guidanceplus iconPostmortem GuidancePotential Exposure at WorkPandemic Planning ScenariosCOVID-19SurgeStaff ShortagesElectronic Case ReportingTrainingNon-US Healthcare Settingsplus iconCOVID-19 & IPC OverviewTriaging Sick PatientsOutpatient FacilitiesAdditional Tools and ResourcesLab Professionalsplus iconTestingplus iconAntigen Testing GuidelinesNucleic Acid Amplification TestsPoint-of-Care & Rapid TestingOther Diagnostic TestsFlu SARS-CoV-2 Multiplex AssayReporting Lab Dataplus iconReporting SARS-CoV-2 Sequencing ResultsBiosafety for Specimen HandlingSpecimen CollectionHealth Departmentsplus iconSurveillance & Data Analyticsplus iconReporting COVID-19 CasesElectronic Case ReportingCOVIDTracer & COVIDTracer AdvancedSprayers Safety PrecautionsCommunication Resourcesplus iconPrint ResourcesVideosPeople with Intellectual & Developmental Disabilitiesplus iconResources for People with IDDEasy to ReadBraille 

 email_03Get Email Updates To receive email updates about COVID-19, enter your email address: Email Address What's this? Submit 

About CDC
Contact Us
800-232-4636

Facebook
Twitter
Instagram
LinkedIn
Youtube
Pinterest
Snapchat


	CONTACT CDC
	

Contact Us

Call 800-232-4636

Email Us


	ABOUT CDC
	

About CDC
Jobs
Funding


	POLICIES
	

Accessibility
External Links
Privacy
Policies
No Fear Act
FOIA
OIG
Nondiscrimination
Vulnerability Disclosure Policy


	CONNECT WITH US
	

Facebook
Twitter
Instagram
LinkedIn

Youtube
Coronavirus Disease 2019 (COVID-19) | CDC
and MethodsCOVID-19 Data SourcesForecastingplus iconHospital ForecastsVariant Surveillanceplus iconGenomic SurveillanceTracking VariantsHealthcare Workersplus iconClinical Careplus iconQuick ReferenceClinical Care ConsiderationsOutpatient Treatment OverviewUnderlying Medical ConditionsChildrenPost-COVID Conditions: Healthcare ProvidersPost-COVID Conditions: CDC ScienceTestingplus iconTesting OverviewAntibody TestingInfection Control Guidanceplus iconPostmortem GuidancePotential Exposure at WorkPandemic Planning ScenariosCOVID-19SurgeStaff ShortagesElectronic Case ReportingTrainingNon-US Healthcare Settingsplus iconCOVID-19 & IPC OverviewTriaging Sick PatientsOutpatient FacilitiesAdditional Tools and ResourcesLab Professionalsplus iconTestingplus iconAntigen Testing GuidelinesNucleic Acid Amplification TestsPoint-of-Care & Rapid TestingOther Diagnostic TestsFlu SARS-CoV-2 Multiplex AssayReporting Lab Dataplus iconReporting SARS-CoV-2 Sequencing ResultsBiosafety for Specimen HandlingSpecimen CollectionHealth Departmentsplus iconSurveillance & Data Analyticsplus iconReporting COVID-19 CasesElectronic Case ReportingCOVIDTracer & COVIDTracer AdvancedSprayers Safety PrecautionsCommunication Resourcesplus iconPrint ResourcesVideosPeople with Intellectual & Developmental Disabilitiesplus iconResources for People with IDDEasy to ReadBraille 

COVID-19 UPDATES
Get email updates about COVID-19

Enter your Email Address to sign up


 Submit
 

FEDERAL RESOURCES

USA.gov/Coronavirus

Treatment Options for COVID-19

About CDC
Contact Us
800-232-4636

Facebook
Twitter
Instagram
LinkedIn
Youtube
Pinterest
Snapchat


	CONTACT CDC
	

Contact Us

Call 800-232-4636

Email Us


	ABOUT CDC
	

About CDC
Jobs
Funding


	POLICIES
	

Accessibility
External Links
Privacy
Policies
No Fear Act
FOIA
OIG
Nondiscrimination
Vulnerability Disclosure Policy


	CONNECT WITH US
Long COVID
While most people with COVID-19 get better within a couple of weeks, some continue to have symptoms or develop new ones after their initial recovery. Long COVID, or Post-Acute Sequelae of SARS-CoV-2 (PASC), is a condition in which individuals infected with COVID-19 continue to experience a wide range of physical, mental, emotional, and psychological symptoms after their initial infection, impacting their daily lives.
Long COVID has affected people around the world and across the United States, including a portion of the population here in New York State. Long COVID may also be known as post-COVID conditions, long-haul COVID, post-acute COVID-19, long-term effects of COVID, or chronic COVID.
How do I know if I have long COVID?
Currently, there is no test to diagnose long COVID. Patients with long COVID often report similar symptoms, including experiencing new, ongoing, or worsening health conditions long after their initial infection. Typically, symptoms that last four or more weeks after a COVID-19 infection could be an indication of long COVID. New Yorkers who have, or had, COVID-19 and are not getting better should contact a health care provider to discuss their symptoms.
What are the symptoms of long COVID?
Even if an individual's initial COVID-19 illness is not severe, long COVID symptoms can still occur. Unfortunately, symptoms have been reported to last for months or even years.
Symptoms associated with long COVID can vary widely, from cardiovascular symptoms like heart palpitations to difficulty breathing and excessive fatigue. Symptoms can also include difficulty concentrating or other psychological manifestations.
The most commonly reported symptoms associated with long COVID are:

Tiredness or fatigue that interferes with daily life
Brain fog
Symptoms that get worse after working hard or thinking hard (also known as 'post-exertional malaise')
Fever

Respiratory and heart symptoms, such as:

Difficulty breathing or shortness of breath
Cough
Chest pain
Fast-beating or pounding heart

Nervous system symptoms, including:

Difficulty thinking or concentrating
Headache
Sleep problems
Dizziness when you stand up (lightheadedness)
Información para entender cómo actúan las vacunas contra el COVID-19 | CDC
UU.ícono de másVisión general sobre el COVID-19 y la prevención y el control de infeccionesClasificación de pacientes enfermosEstablecimientos para pacientes ambulatoriosHerramientas y recursos adicionalesProfesionales de laboratorioícono de másPruebas de detecciónícono de másGuías para las pruebas de antígenosPruebas de amplificación de ácido nucleicoPruebas rápidas y en puntos de atenciónOtras pruebas de diagnósticoPrueba de diagnóstico multiplex para la influenza y el SARS-CoV-2Reporte de datos de laboratorioícono de másNotificación de los resultados de secuenciación del SARS-CoV-2Bioseguridad para la manipulación de muestrasRecolección de muestrasDepartamentos de saludícono de másVigilancia y análisis de datosícono de másNotificación de casos de COVID-19Notificación electrónica de casosCOVIDTracer y COVIDTracer AdvancedPrecauciones de seguridad para rociadoresRecursos de comunicaciónícono de másRecursos para imprimirVideosPersonas con discapacidades intelectuales y del desarrolloícono de másRecursos para personas con discapacidades intelectuales y del desarrolloDe fácil lecturaBraille 

 correo_electrónico_03Reciba actualizaciones por correo electrónico Para recibir actualizaciones del COVID-19, ingrese su dirección de correo electrónico: Correo electrónico Información Enviar 

Acerca de los CDC
Contáctenos
800-232-4636

Facebook
Twitter
Instagram
LinkedIn
Youtube
Pinterest
Snapchat

 COMUNÍQUESE CON CDC 

Contáctenos

Llame al 800-232-4636
COVID-19 Overview and Infection Prevention and Control Priorities in non-U.S. Healthcare Settings | CDC
It is important to note that some people become infected and do not develop any symptoms or feel ill.
People at Higher Risk for Severe Illness
COVID-19 is a relatively new disease; therefore, additional risk factors for severe COVID-19 may continue to be identified. In some cases, people who get COVID-19 can develop severe complications, including difficulty breathing, causing a need for hospitalization and intensive care. 5 These severe complications often lead to death. The risk of severe disease increases steadily as people age. Additionally, those of all ages with underlying medical conditions, including but not limited to heart disease, diabetes or lung disease, are  at higher risk to develop severe COVID-19 compared to those without these conditions.5 Those at higher risk for severe illness should be prioritized for vaccination.6
Top of PageCOVID-19 Preventative Actions
COVID-19 can be prevented through pharmaceutical (i.e., vaccination) and non-pharmaceutical interventions (e.g., masking, physical distancing, hand hygiene). All of these preventative measures are important to protect individuals from acquiring and transmitting the SARS-CoV-2 virus and should be done in conjunction with one another.
Vaccination
Getting vaccinated is a preventative measure that people can take to avoid getting sick with COVID-19 and to avoid infecting others. While safe and effective vaccines are a great tool for prevention, it is important to continue other preventative actions such as wearing masks, performing hand hygiene, physically distancing from others, and avoiding crowded spaces and spaces with poor ventilation.7  There are several vaccine candidates, and many have been listed under WHO’s emergency use.
Masks
Wearing masks is another important preventative action for COVID-19 that should continue to be performed. When selecting a mask, there are many factors to consider.8 Masks should

Have two or more layers of washable, breathable fabric
Completely cover the nose and mouth
Fit snug against the sides of the face and not have gaps
Have a nose wire to prevent air from leaking out of the top of the mask
Coronavirus FAQs: What Veterans Need To Know | Veterans Affairs
If your symptoms get worse, contact your provider or nearest VA health facility. To get reminders for when to contact your care team or a nurse advice line, you can use our Annie text messaging service.
Subscribe to the Annie text messaging service

If you have any signs of emergency, call 911 or get help right away. Signs of emergency include symptoms like trouble breathing or continued pain or pressure in your chest.
Get the latest COVID-19 symptom information on the CDC website

Note: If your self-test results are positive, you don’t need to schedule a lab test.
Get answers to more questions about COVID-19 testing at VA

COVID-19 symptoms, treatment, and research

If you have any of these emergency warning signs, call 911 to get help now: 

Trouble breathing 
Persistent (continuing) pain or pressure in the chest 
Bluish lips or face 
Suddenly feeling or acting confused 
Trouble waking up or staying awake 

If you have other symptoms of COVID-19, request a lab test appointment at VA or take a self-test at home. If your result is positive, tell your health care team right away. If you need treatment, you must start it early for it to work. Some treatments must start within 5 days of your first symptoms.
Check COVID-19 symptoms on the CDC website
Get answers to more questions about COVID-19 testing at VA
If you have symptoms of COVID-19, contact us before going to a VA health facility. Contacting us first helps us keep you and others safe.  

Get your facility's phone number to call before you come in
Send your VA provider a secure message about your symptoms

Our Annie text messaging service can help you monitor your symptoms
This service can advise you when to contact your VA care team or your facility’s advice nurse. It also provides general wellness tips and steps you can take to protect yourself. You can ask your VA care team to assign the service to you. Or, you can subscribe to Annie coronavirus precautions messages yourself. 
Subscribe to Annie coronavirus precautions messages

First, know that you're not alone.
Long COVID
Long COVID

skip to main content


 Your browser does not support iFrames
 

Navigation menu

Department of Health

Individuals/Families

COVID-19 Vaccine
Birth, Death, Marriage & Divorce Records
Health Insurance Programs
Consumer Health Care Information
Community Health
Healthy Lifestyles
Health & Safety in the Home, Workplace & Outdoors
Diseases & Conditions
Data & Reports
Health Topics A to Z

Providers/Professionals

Novel Coronavirus
Narcotic Enforcement
EMS
Health Initiatives
Data & Reports
Diseases & Conditions
Patient Resources
Disease Reporting
Clinical Guidelines, Standards & Quality of Care
Permits, Licenses & Certification
All Health Care Professionals & Patient Safety
Health Topics A to Z

Health Facilities

Compare Health Care Providers
Adult Care Facilities/Assisted Living
Home Care & Hospice
Hospitals & Clinics
New York State Veterans Homes
Nursing Homes
School Based Health Centers
All Health Care Facilities
Health Topics A to Z

Health Data

Open Health Data
NYS Health Connector
Data & Reports

About Us

About the Department
Related Sites
Health Topics A to Z

Search

You are Here: Home Page
>
 Diseases and Conditions
> Long COVID

Long COVID

To support New Yorkers with long COVID, this webpage is available in an audio format. Listen to the frequently asked questions and answers here.
Understanding long COVID
What is long COVID?
While most people with COVID-19 get better within a couple of weeks, some continue to have symptoms or develop new ones after their initial recovery. Long COVID, or Post-Acute Sequelae of SARS-CoV-2 (PASC), is a condition in which individuals infected with COVID-19 continue to experience a wide range of physical, mental, emotional, and psychological symptoms after their initial infection, impacting their daily lives.
Long COVID has affected people around the world and across the United States, including a portion of the population here in New York State.
Information for Providers | Department of Health
Information for Providers | Department of Health

 Skip to main content
 

 Your browser does not support iFrames
 

Navigation Menu Toggle

 COVID-19

VaccineVaccineVaccine Safety Vaccine for ChildrenVaccine for Pregnant New YorkersFAQsTestingTreatmentPrevention & SymptomsDataProvidersProvidersOral AntiviralsMonoclonal Antibody TherapeuticsVaccine InformationGuidanceNews

Information for Providers

TOP
Information for Providers

SHARE

Share by Email

Share by Facebook

Share by Twitter

Sections

See All

 Overview
 
 
 

Providers, please encourage patients to stay up to date with COVID-19 vaccines and to contact you or another health care provider if they test positive, as both vaccination and treatment can reduce the chances of severe COVID-19 and hospitalization.  You will find information below on current treatment options, vaccine resources for providers, current guidance documents, and more.

 Oral Antivirals
 
 
 

OverviewOral antiviral treatment works by targeting specific proteins on the SARS-CoV-2 virus to prevent efficient virus replication within the host cell. Paxlovid and molnupiravir reduce the risk of hospitalization and death by 88% and 30% respectively, in patients at high-risk for severe COVID-19 when started early after symptom onset. As of November 1st, 2023, COVID-19 antivirals, Paxlovid and Lagevrio (molnupiravir), will begin their transition from United State Government distribution to traditional commercial channels. Please refer to the Commercialization section for more information regarding this transition. EligibilityThe FDA authorized two oral antivirals, Pfizer's Paxlovid and Merck's molnupiravir, for the treatment of COVID-19 in certain patients who: Have tested positive for COVID-19 and have had symptoms for 5 days or less. Are at high risk for progression to severe COVID-19, including hospitalization or death. Meet certain criteria depending on the antiviral.
Standard Operating Procedure (SOP) for Triage of Suspected COVID-19 Patients in non-US Healthcare Settings: Early Identification and Prevention of Transmission during Triage | CDC
COVID-19 spreads when an infected person breathes out droplets and very small particles that contain the virus. These droplets and particles can be breathed in by other people or land on their eyes, noses, or mouth. In some circumstances, they may contaminate surfaces they touch. People who are closer to the infected person are most likely to get infected. For more information on SARSCoV-2 transmission, refer to COVID-19 Data & Surveillance.
2. What healthcare facilities can do to minimize risk of infection among patients and healthcare workers
Communicate with patients before arriving for triage

Establish a hotline that:

Patients can call or text notifying the facility that they are seeking care due to COVID-19 symptoms.
Can be used, if possible, as telephone consultation for patients to determine the need to visit a healthcare facility.
Serves to inform patients of preventive measures to take as they come to the facility (e.g., wearing mask, having tissues to cover cough or sneeze).

Provide information to the general public through local mass media such as radio, television, newspapers, and social media platforms about:

Availability of a hotline with information on the signs and symptoms of COVID-193.
Importance of notifying healthcare providers if they are seeking care due to COVID-19 symptoms before arriving at the facility.
Signs and symptoms of severe COVID-19 disease such as trouble breathing, new confusion, persistent pain or pressure in the chest, or inability to wake or stay awake
Preventive measures, such as mask use4, social distancing, respiratory etiquette, and hand hygiene before and upon arrival to a healthcare facility

Healthcare facilities, in conjunction with national authorities, should consider telemedicine (e.g., telephone, audio-video calls, or secure messaging) to provide clinical support without direct contact with the patient.5

Set up and equip triage

Limit point of entry to the health facility.
Información para entender cómo actúan las vacunas contra el COVID-19 | CDC
de vacunarseMitos y hechosTratamientos y medicamentosAfecciones persistentes al COVID-19ícono de másCuidar de personas con afecciones persistentes al COVID-19Consejos para las citas de pacientesDatos y vigilanciaícono de másRed de vigilancia de hospitalizaciones COVID-NETícono de másPanel de COVID-NETVisión general y métodos de COVID-NETFuentes de datos de COVID-19Pronósticosícono de másPronósticos de hospitalizacionesVigilancia de variantesícono de másVigilancia genómicaSeguimiento de las variantesTrabajadores de la saludícono de másCuidado clínicoícono de másGuía de referencia rápidaConsideraciones de cuidado clínicoVisión general de tratamiento para pacientes ambulatoriosAfecciones subyacentes y otras condicionesNiñosAfecciones posteriores al COVID-19: proveedores de atención médicaAfecciones posteriores al COVID-19: la ciencia y los CDCPruebas de detecciónícono de másVisión general sobre las pruebas de detecciónPrueba de anticuerposPautas para el control de infeccionesícono de másDirectrices post mortemPosible exposición en el trabajoEscenarios de planificación para la pandemiaAumento de casos de COVID-19Escasez de personalNotificación electrónica de casosCapacitaciónEntornos de atención médica fuera de los EE.